Sam Altman, the chief executive of OpenAI, recently invested US$180 million into Retro Biosciences—a company seeking to extend human lifespans by ten healthy years.
The rich are pouring millions into life extension research, but does it have any ethical value?
The Owl Picks
-
One highlight of my Grade 3 life was dying from dysentery at the hands of a video game. I was ahead on schoolwork, and allowed to use the classroom computer to pioneer a family across [...]
-
Your diet — the foods and drinks you eat, not short-term restrictive programs — can impact your heart disease risk. Evidence-based approaches to eating are used by dietitians and physicians to prevent and treat cardiovascular [...]
-
Imagine being stuck in traffic while running late to an important meeting at work. You feel your face overheating as your thoughts start to race along: “they’re going to think I’m a horrible employee,” “my [...]
-
Imagine living with pain every day for months, or even years — pain that is so intrusive, it disrupts every day of your life. Unfortunately, this is the daily reality of millions of people living [...]
-
Professional corporate web design is a critical aspect of building an online presence for any business. It not only reflects the brand image but also helps in establishing trust and credibility with customers. A well-designed [...]
